According to a market report by Lucintel, the future of the global viral vector manufacturing market looks promising with opportunities in the pharmaceutical & biopharmaceutical and research institute markets. The global viral vector manufacturing market is expected to reach an estimated $5,877 million by 2035 with a CAGR of 13.7% from 2025 to 2035. The major drivers for this market are the increasing demand for scalable manufacturing technologies, the growing investments in biotechnology companies, and the rising demand for government funding for life sciences.
A more
than 150-page report to understand trends, opportunity and forecast in global viral
vector manufacturing market to 2035 by type (adenovirus, retrovirus,
adeno-associated virus, lentivirus, plasmid DNA, and others), workflow
(upstream manufacturing and downstream manufacturing), application (cell &
gene therapy, vaccinology, and research & other applications), end use
(pharmaceutical & biopharmaceutical, research institutes, and others), and
region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type category, adeno-associated virus is expected to
witness higher growth over the forecast period.
Within the
end use category, pharmaceutical & biopharmaceutical is expected to witness
the highest growth.
Download
sample by clicking on viral
vector manufacturing market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Merck,
Lonza, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Cobra
Biologics, Catalent, Wuxi Biologics, Takara Bio, Waisman Biomanufacturing,
Genezen Laboratories are the major suppliers in the viral vector manufacturing market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Skin Microbiome Modulation Market
No comments:
Post a Comment